Pneumococcal Conjugate Vaccines Overcome Splenic Dependency of Antibody Response to Pneumococcal Polysaccharides

Author:

Breukels Mijke A.1,Zandvoort Andre2,van den Dobbelsteen Germie P. J. M.3,van den Muijsenberg Adrie1,Lodewijk Monique E.2,Beurret Michel3,Klok Pieter A.2,Timens Wim2,Rijkers Ger T.1

Affiliation:

1. Department of Pediatric Immunology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, 3584 EA Utrecht,1

2. Department of Pathology, University Hospital Groningen, 9713 GZ Groningen,2 and

3. Laboratory for Vaccine Research, National Institute of Public Health and the Environment, 3721 MA Bilthoven,3 The Netherlands

Abstract

ABSTRACT Protection against infections with Streptococcus pneumoniae depends on the presence of antibodies against capsular polysaccharides that facilitate phagocytosis. Asplenic patients are at increased risk for pneumococcal infections, since both phagocytosis and the initiation of the antibody response to polysaccharides take place in the spleen. Therefore, vaccination with pneumococcal polysaccharide vaccines is recommended prior to splenectomy, which, as in the case of trauma, is not always feasible. We show that in rats, vaccination with a pneumococcal conjugate vaccine can induce good antibody responses even after splenectomy, particularly after a second dose. The spleen remains necessary for a fast, primary response to (blood-borne) polysaccharides, even when they are presented in a conjugated form. Coadministration of a conjugate vaccine with additional nonconjugated polysaccharides of other serotypes did not improve the response to the nonconjugated polysaccharides. We conclude that pneumococcal conjugate vaccines can be of value in protecting asplenic or hyposplenic patients against pneumococcal infections.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Reference37 articles.

1. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP);Advisory Committee on Immunization Practices;Morb. Mortal. Wkly. Rep.,1997

2. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants;Ahman H.;Pediatr. Infect. Dis. J.,1996

3. Splenic dependence of the antibody response to thymus-independent (TI-2) antigens;Amlot P. L.;Eur. J. Immunol.,1985

4. Impaired human antibody response to the thymus-independent antigen, DNP-Ficoll, after splenectomy. Implications for post-splenectomy infections;Amlot P. L.;Lancet,1985

5. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy;Ammann A. J.;N. Engl. J. Med.,1977

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3